Catalyst Wire Dossier Catalyst Wire Dossier

[F-18] fluoroDOPA

fluoroDOPA labeled with Fluorine-18
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for [F-18] fluoroDOPA, covering 2022-11-09 to 2022-11-09. Get the full timeline:

Most recent: Clinical Trial Update: Utility of [F-18] fluoroDOPA for Neonatal Hyperinsulinism [Phase 2]

See pricing